T1	Condition 22 26	COPD
T2	Condition 31 33	HF
*	OR T2 T1
T3	Procedure 50 68	clinical treatment
T4	Qualifier 40 49	optimized
R1	Has_qualifier Arg1:T3 Arg2:T4	
T5	Scope 22 33	COPD and HF
R2	AND Arg1:T5 Arg2:T3	
T6	Value 110 117	Reduced
T7	Measurement 118 152	left ventricular ejection fraction
T8	Value 154 158	<50%
R3	Has_value Arg1:T7 Arg2:T6	
R4	Subsumes Arg1:T6 Arg2:T8	
T9	Condition 176 194	airway obstruction
T10	Qualifier 161 175	Non-reversible
R5	Has_qualifier Arg1:T9 Arg2:T10	
T11	Measurement 216 224	FEV1/FVC
T12	Qualifier 196 215	post-bronchodilator
R6	Has_qualifier Arg1:T11 Arg2:T12	
T13	Value 225 230	< 0.7
T14	Measurement 235 239	FEV1
T15	Value 240 246	< 80 %
R7	Has_qualifier Arg1:T14 Arg2:T12	
R8	Has_value Arg1:T14 Arg2:T15	
R9	Has_value Arg1:T11 Arg2:T13	
T16	Scope 196 246	post-bronchodilator FEV1/FVC < 0.7 and FEV1 < 80 %
T17	Scope 161 194	Non-reversible airway obstruction
R10	Subsumes Arg1:T17 Arg2:T16	
T18	Condition 249 276	Respiratory muscle weakness
T19	Measurement 278 284	Pi,max
T20	Value 285 294	< 70cmH2O
R11	Has_value Arg1:T19 Arg2:T20	
T21	Condition 308 329	dyspnea on daily life
T22	Temporal 297 307	Persistent
R12	Has_temporal Arg1:T21 Arg2:T22	
T23	Temporal 331 339	Baseline
T24	Measurement 340 365	Dyspnea Index focal score
T25	Value 366 372	<or= 8
R13	Has_value Arg1:T24 Arg2:T25	
R14	Has_temporal Arg1:T24 Arg2:T23	
T26	Scope 331 372	Baseline Dyspnea Index focal score <or= 8
T27	Scope 297 329	Persistent dyspnea on daily life
R15	Subsumes Arg1:T27 Arg2:T26	
